$5.38
-0.60-9.95%
al cierre: Nov 16, 4:00 PM EST
$5.97
0.5810.86%
After hour: 9:30 AM EST

Eikon Therapeutics (EIKN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-1.59 | $-1.63 | 2.45 % |
| Q2 | Aug 13, 2026 | $-1.63 | $-1.49 | -9.40 % |
| Q1 | May 11, 2026 | $-2.46 | $-4.07 | 39.6 % |
| Q4 | Mar 30, 2026 | $-1.48 | $-1.58 | 6.33 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.63 | $-1.49 | $-4.07 | $-1.58 |
| Actual | $-1.59 | $-1.63 | $-2.46 | $-1.48 |
| Surprise | +2.45% | -9.40% | +39.6% | +6.33% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.54 | $-1.62 | $-1.90 | $-1.97 |
| Revenue | ||||
| Consensus | — | — | — | — |